Given the central importance of B-cell activation in MCL through the BCR pathway [23], we hypothesized that MCL cells may also significantly recruit SAE1 and SAE2 to drive their proliferation and survival and thus may be a novel therapeutic vulnerability in proliferative MCL. Here, SAE1 is linked to mantle cell lymphoma.